These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 86215)

  • 21. The Kell and XK proteins of the Kell blood group are not co-expressed in the central nervous system.
    Clapéron A; Hattab C; Armand V; Trottier S; Bertrand O; Ouimet T
    Brain Res; 2007 May; 1147():12-24. PubMed ID: 17379193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Kmod blood group phenotype in a healthy individual.
    Winkler MM; Beattie KM; Cisco SL; Sigmund KE; Johnson CL; Rabin BI; Marsh WL
    Transfusion; 1989 Sep; 29(7):642-5. PubMed ID: 2773032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Onset of expression of the components of the Kell blood group complex.
    Pu JJ; Redman CM; Visser JW; Lee S
    Transfusion; 2005 Jun; 45(6):969-74. PubMed ID: 15934996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful transfusion of Kp (a-b+) red cells incompatible for auto anti-Kpb.
    Villa MA; Coluccio E; Revelli Nicoletta ; Drago F; Morelati F; Rebulla P
    Haematologica; 2005 Jan; 90(1):ECR07. PubMed ID: 16791926
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune hemolytic anemia associated with anti-Kell and a carrier state for chronic granulomatous disease.
    Garratty G; Sattler MS; Petz LD; Flannery EP
    Rev Fr Transfus Immunohematol; 1979 Dec; 22(5):529-49. PubMed ID: 547351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A further example of Kp1/Ko exhibiting depression of some Kell group antigens.
    Ford DS; Knight AE; Smith F
    Vox Sang; 1977; 32(4):220-3. PubMed ID: 855255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides.
    Carbonnet F; Hattab C; Collec E; Le van Kim C; Cartron JP; Bertrand O
    Br J Haematol; 1997 Mar; 96(4):857-63. PubMed ID: 9074432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An autoanti-Kp b immunoglobulin M that simulates antigen suppression.
    Bosco A; Xenocostas A; Kinney J; Cadwell CM; Zimring JC
    Transfusion; 2009 Apr; 49(4):750-6. PubMed ID: 19170996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human granulocytes lack red cell Kx antigen.
    Branch DR; Gaidulis L; Lazar GS
    Br J Haematol; 1986 Apr; 62(4):747-55. PubMed ID: 3516199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of a Kell-reactive protein from red cell membranes.
    Wallas C; Simon R; Sharpe MA; Byler C
    Transfusion; 1986; 26(2):173-6. PubMed ID: 3952793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 'new' allele, Kpc, at the Kell complex locus.
    Yamaguchi H; Okubo Y; Seno T; Matsushita K; Daniels GL
    Vox Sang; 1979; 36(1):29-30. PubMed ID: 425420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Côté serum (anti-K11), an antibody defining a new variant in the Kell system.
    Guévin RM; Taliano V; Waldmann O
    Vox Sang; 1976; 31(1 SUPPL):96-100. PubMed ID: 1007153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoanti-K antibody mimicking an alloantibody.
    Viggiano E; Clary NL; Ballas SK
    Transfusion; 1982; 22(4):329-32. PubMed ID: 7101426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocyte morphology in genetic defects of the Rh and Kell blood group systems.
    Taswell HF; Lewis JC; Marsh WL; Wimer BM; Pineda AA; Brzica SM
    Mayo Clin Proc; 1977 Mar; 52(3):157-9. PubMed ID: 402512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. K23. A low-incidence antigen in the Kell blood group system identified by biochemical characterization.
    Marsh WL; Redman CM; Kessler LA; DiNapoli J; Scarborough AL; Philipps AG; Mody KM
    Transfusion; 1987; 27(1):36-40. PubMed ID: 3810821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed hemolytic transfusion reaction caused by the second example of anti-K19.
    Marsh WL; DiNapoli J; Oyen R; Greenspan R; Hu A; Rincon F
    Transfusion; 1979; 19(5):604-8. PubMed ID: 505537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of Kell-active protein from the red cell membrane.
    Redman CM; Marsh WL; Mueller KA; Avellino GP; Johnson CL
    Transfusion; 1984; 24(2):176-8. PubMed ID: 6200970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic granulomatous disease, Kx antigen and the Kell blood groups.
    Marsh WL
    Prog Clin Biol Res; 1978; 21():493-511. PubMed ID: 566439
    [No Abstract]   [Full Text] [Related]  

  • 39. Hemolytic transfusion reaction due to interdonor kell incompatibility. Report of two cases and review of the literature.
    Reiner AP; Sayers MH
    Arch Pathol Lab Med; 1990 Aug; 114(8):862-4. PubMed ID: 2198004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Wrb, and other autoantibodies responsible for positive direct antiglobulin tests in 150 individuals.
    Issitt PD; Pavone BG; Goldfinger D; Zwikder H; Issitt CH; Tessel JA; Kroovand SW; Bell CA
    Br J Haematol; 1976 Sep; 34(1):5-18. PubMed ID: 952768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.